Juno Therapeutics (Germany)
Juno Therapeutics, Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Juno Therapeutics (Germany), Germany, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
61%
Total
Publications
128
Total Open
Publications
78
Total
Citations
6.9K
Open Access
Percentage
61%
Total
Publications
128
Total Open
Publications
78
Total
Citations
6.9K
Breakdown
Publisher Open
30%
Both
18%
Other Platform Open
11%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
17
Hybrid 37%
22
No Guarantees 34%
20
Other Platform Open
Institution 50%
18
Domain 47%
17
Preprint 17%
6
Other Internet 11%
4
Public 3%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 17 |
LA Referencia | Institution | 11 |
doaj.org OAI-PMH Repository | Institution | 8 |
aecid.es OAI-PMH Repository | Institution | 5 |
bioRxiv | Preprint | 4 |
Technical University of Munich | Institution | 3 |
DOI | Other Internet | 3 |
The University of Western Australia | Institution | 2 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
Unknown Repository | Other Internet | 1 |